- Previous Close
25.25 - Open
25.25 - Bid 25.75 x --
- Ask 26.00 x --
- Day's Range
24.60 - 26.00 - 52 Week Range
16.80 - 27.50 - Volume
7,398,504 - Avg. Volume
2,408,801 - Market Cap (intraday)
20.051B - Beta (5Y Monthly) --
- PE Ratio (TTM)
28.98 - EPS (TTM)
0.88 - Earnings Date Feb 18, 2025 - Feb 24, 2025
- Forward Dividend & Yield 0.45 (1.78%)
- Ex-Dividend Date Nov 22, 2024
- 1y Target Est
29.31
Praram 9 Hospital Public Company Limited engages in hospital operations primarily in Thailand. The company operates medicine, surgery, diabetes and metabolic, spine, orthopedic, physical therapy and rehabilitation, chest and respiratory, neurology, thyroid and thyroid surgery, obstetrics gynecology, IVF, breast, oncocare, emergency, imaging, Lasik, skin and plastic surgery, mind, gastrointestinal and liver disease, dental, check-up, eye, pediatric, sleep, ear, nose, and throat centers, as well as breast, and vaccination and travel medicine clinics. It is also involved in the operation of kidney disease and transplantation, cardiovascular, and pain management and wellness institutes. Praram 9 Hospital Public Company Limited was founded in 1992 and is based in Bangkok, Thailand.
www.praram9.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: PR9.BK
View MorePerformance Overview: PR9.BK
Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PR9.BK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PR9.BK
View MoreValuation Measures
Market Cap
19.85B
Enterprise Value
17.63B
Trailing P/E
28.69
Forward P/E
24.39
PEG Ratio (5yr expected)
1.41
Price/Sales (ttm)
4.36
Price/Book (mrq)
3.71
Enterprise Value/Revenue
3.87
Enterprise Value/EBITDA
15.14
Financial Highlights
Profitability and Income Statement
Profit Margin
15.07%
Return on Assets (ttm)
8.39%
Return on Equity (ttm)
13.57%
Revenue (ttm)
4.61B
Net Income Avi to Common (ttm)
694.15M
Diluted EPS (ttm)
0.88
Balance Sheet and Cash Flow
Total Cash (mrq)
2.23B
Total Debt/Equity (mrq)
0.11%
Levered Free Cash Flow (ttm)
627.47M